For research use only
| Cat No. | ABC-TC3354 |
| Product Type | Immune Cells |
| Cell Type | B Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Chronic Lymphoid Leukemia |
| Storage | Liquid Nitrogen |
Human Chronic Lymphoid Leukemia Peripheral Blood CD19+/CD5+ B Cells are useful for biomarker analysis, disease modeling, and immunotherapy development.
Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia peripheral blood mononuclear cells using a direct immunomagnetic CD19+ MicroBead labeling system. Available in untreated or relapsed/refractory stages.
The co-expression of CD5 is typically found on cancerous Chronic Lymphoid LeukemiaCD19+ B cells. Current research is underway to identify the Chronic Lymphoid Leukemia clonal origin of Chronic Lymphoid Leukemia from this cell population. Although these cells appear mature in morphology, they are in developmental arrest. Researchers have shown that only 1% of these cells are in an active cycle. CD19+/CD5+ B cells play an important role in production of IgM autoantibodies.
| Species | Human |
| Cat.No | ABC-TC3354 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | B Cell |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Chronic Lymphoid Leukemia |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Immune Cells |
For research use only
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).